You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 7, 2025

Drug Price Trends for NDC 42858-0405


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 42858-0405

Drug NameNDCPrice/Unit ($)UnitDate
APTENSIO XR 40 MG CAPSULE 42858-0405-45 7.96152 EACH 2025-03-19
APTENSIO XR 40 MG CAPSULE 42858-0405-45 7.96896 EACH 2025-02-19
APTENSIO XR 40 MG CAPSULE 42858-0405-45 7.98032 EACH 2025-01-22
APTENSIO XR 40 MG CAPSULE 42858-0405-45 7.98469 EACH 2024-12-18
APTENSIO XR 40 MG CAPSULE 42858-0405-45 7.99649 EACH 2024-11-20
APTENSIO XR 40 MG CAPSULE 42858-0405-45 7.99649 EACH 2024-10-23
APTENSIO XR 40 MG CAPSULE 42858-0405-45 8.01021 EACH 2024-09-18
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 7 of 7 entries

Best Wholesale Price for NDC 42858-0405

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
APTENSIO XR 40MG Rhodes Pharmaceuticals L.P. 42858-0405-45 90 588.19 6.53544 2021-02-15 - 2026-02-14 FSS
APTENSIO XR 40MG Rhodes Pharmaceuticals L.P. 42858-0405-45 90 588.19 6.53544 2022-01-01 - 2026-02-14 FSS
APTENSIO XR 40MG Rhodes Pharmaceuticals L.P. 42858-0405-45 90 588.19 6.53544 2023-01-01 - 2026-02-14 FSS
APTENSIO XR 40MG Rhodes Pharmaceuticals L.P. 42858-0405-45 90 552.74 6.14156 2021-02-15 - 2026-02-14 Big4
APTENSIO XR 40MG Rhodes Pharmaceuticals L.P. 42858-0405-45 90 552.74 6.14156 2022-01-01 - 2026-02-14 Big4
APTENSIO XR 40MG Rhodes Pharmaceuticals L.P. 42858-0405-45 90 552.74 6.14156 2023-01-01 - 2026-02-14 Big4
APTENSIO XR 40MG Rhodes Pharmaceuticals L.P. 42858-0405-45 90 552.74 6.14156 2024-01-01 - 2026-02-14 Big4
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 7 of 7 entries

Market Analysis and Price Projections for Oxycodone Hydrochloride (NDC: 42858-0405)

The pharmaceutical industry is constantly evolving, with drug pricing and market dynamics playing crucial roles in shaping its future. In this comprehensive analysis, we'll delve into the market trends and price projections for Oxycodone Hydrochloride, specifically focusing on the National Drug Code (NDC) 42858-0405.

Understanding Oxycodone Hydrochloride

Oxycodone Hydrochloride is a potent opioid analgesic used for the management of moderate to severe pain. As a controlled substance, its pricing and market dynamics are subject to various factors, including regulatory oversight and public health concerns.

The Significance of NDC 42858-0405

The National Drug Code (NDC) 42858-0405 specifically identifies a particular formulation and packaging of Oxycodone Hydrochloride. This unique identifier helps in tracking the drug's distribution, pricing, and market presence[7].

Current Market Trends

The pharmaceutical market, particularly for opioid medications, has been undergoing significant changes in recent years. These shifts are driven by factors such as increased scrutiny on opioid prescribing practices, the rise of alternative pain management strategies, and evolving healthcare policies.

Pricing Dynamics

Recent data shows a fluctuating pricing trend for Oxycodone Hydrochloride. For instance:

  • In October 2024, the price per unit was $0.16562
  • By November 2024, it decreased to $0.11861
  • In December 2024, it slightly increased to $0.13848[1]

This volatility reflects the complex interplay of market forces affecting opioid medications.

Market Competition

The generic drug market, which includes various formulations of Oxycodone Hydrochloride, is highly competitive. This competition typically leads to price erosion over time, a trend that's expected to continue in the coming years.

In the generic drug market, prices are expected to erode annually by mid-single-digit percentages. This trend is consistent with the current outlook for the pharmaceutical industry, where revenue growth is modest but stable.[2]

Future Price Projections

Based on current trends and industry analyses, we can make several projections for the pricing of Oxycodone Hydrochloride (NDC: 42858-0405) in the coming years.

Annual Price Erosion

Industry experts anticipate an annual price erosion of approximately 3-5% for generic drugs like Oxycodone Hydrochloride. This projection is based on factors such as market competition and regulatory pressures[2].

Projected Pricing Scenario

Assuming a starting price of $100 per unit in 2024 (for illustrative purposes), here's a potential pricing scenario for the next few years:

Year Projected Price per Unit
2024 $100.00
2025 $95.00
2026 $90.25
2027 $85.74
2028 $81.45

This projection assumes a 5% annual price erosion, which is at the higher end of the expected range for generic drugs[2].

Factors Influencing Future Pricing

Several key factors will play a role in shaping the future pricing of Oxycodone Hydrochloride:

Regulatory Environment

The regulatory landscape for opioid medications continues to evolve. Stricter controls and potential policy changes could impact both the demand and pricing of these drugs.

Market Competition

As more generic versions enter the market, increased competition could drive prices down further. Companies may need to adjust their pricing strategies to maintain market share.

Healthcare Policy Changes

Potential shifts in healthcare policies, particularly those related to drug pricing and opioid prescribing practices, could significantly impact the market for Oxycodone Hydrochloride.

Technological Advancements

Innovations in pain management, including non-opioid alternatives and novel drug delivery systems, could influence the demand and pricing of traditional opioid medications.

Impact of Political Landscape

The political environment plays a crucial role in shaping pharmaceutical policies and, consequently, drug pricing. The upcoming years, particularly 2025, are expected to bring significant changes to the industry landscape.

New Administration's Impact

With the incoming Trump administration in 2025, there's potential for shifts in healthcare policies that could affect drug pricing and market dynamics. The appointment of key figures in health-related positions may lead to changes in regulatory approaches and priorities[5].

Drug Pricing Policies

The new administration's stance on drug pricing could have far-reaching effects on the pharmaceutical industry, potentially influencing pricing strategies for drugs like Oxycodone Hydrochloride.

Market Opportunities and Challenges

While the opioid market faces challenges, there are also potential opportunities for companies operating in this space.

Opportunities

  • Development of abuse-deterrent formulations
  • Expansion into emerging markets
  • Partnerships with healthcare providers for responsible prescribing practices

Challenges

  • Increasing regulatory scrutiny
  • Public health concerns related to opioid use
  • Competition from alternative pain management solutions

Global Market Perspective

While our focus has been on the U.S. market, it's important to consider the global context of opioid medications.

International Pricing Comparisons

The U.S. typically has higher drug prices compared to other developed countries. This disparity could potentially influence future pricing strategies and regulatory approaches[8].

Global Market Growth

The global pharmaceutical market is projected to grow significantly:

Looking at the overall outlook for the global biotech market in 2025, however, there is a cautious optimism in the air: it is projected to expand from $483.0 billion in 2024 to $546.0 billion by 2025, reflecting a robust compound annual growth rate (CAGR) of approximately 13%.[5]

This growth could have indirect effects on the pricing and market dynamics of specific drugs like Oxycodone Hydrochloride.

Strategies for Stakeholders

Given the projected market trends and pricing dynamics, various stakeholders in the pharmaceutical industry may need to adapt their strategies.

For Pharmaceutical Companies

  • Focus on cost-effective production methods to maintain profitability despite price erosion
  • Invest in research and development of abuse-deterrent formulations
  • Explore partnerships with healthcare providers and payers for value-based pricing models

For Healthcare Providers

  • Stay informed about pricing trends to make cost-effective prescribing decisions
  • Implement robust pain management protocols that consider both opioid and non-opioid options
  • Engage in ongoing education about responsible opioid prescribing practices

For Payers and PBMs

  • Develop formularies that balance cost considerations with patient access to necessary medications
  • Implement programs to monitor and manage opioid utilization
  • Explore innovative contracting models with pharmaceutical companies

Future of Pain Management

The evolving landscape of pain management will likely influence the market for opioid medications like Oxycodone Hydrochloride.

Emerging Alternatives

Research into non-opioid pain management solutions is ongoing. Advances in this area could potentially reshape the market for traditional opioid medications.

Personalized Medicine

The trend towards personalized medicine could lead to more targeted use of opioid medications, potentially affecting overall demand and pricing.

Key Takeaways

  • The pricing of Oxycodone Hydrochloride (NDC: 42858-0405) is expected to experience annual erosion of 3-5% due to market competition and regulatory pressures.
  • Political changes, particularly the incoming administration in 2025, could significantly impact drug pricing policies and market dynamics.
  • The global pharmaceutical market is projected to grow, which may indirectly influence pricing strategies for specific drugs.
  • Stakeholders in the pharmaceutical industry, including companies, healthcare providers, and payers, will need to adapt their strategies to navigate the changing landscape.
  • The future of pain management, including the development of non-opioid alternatives and personalized medicine approaches, could reshape the market for opioid medications.

FAQs

  1. How does the NDC system work for drug identification? The National Drug Code (NDC) is a unique, three-segment number that identifies the labeler, product, and package size of a drug. It helps in tracking distribution, pricing, and market presence of specific drug formulations[7].

  2. What factors contribute to the pricing of generic drugs like Oxycodone Hydrochloride? Factors include market competition, regulatory pressures, production costs, demand fluctuations, and overall healthcare policy trends[2].

  3. How might the political landscape in 2025 affect drug pricing? The incoming administration's healthcare policies and appointments to key positions could lead to changes in drug pricing regulations and market dynamics[5].

  4. What are some emerging trends in pain management that could affect the opioid market? Emerging trends include the development of non-opioid pain management solutions, personalized medicine approaches, and abuse-deterrent formulations of existing medications.

  5. How does the U.S. pharmaceutical market compare to global markets in terms of pricing? The U.S. typically has higher drug prices compared to other developed countries, which could influence future pricing strategies and regulatory approaches[8].

Sources cited: [1] https://www.drugpatentwatch.com/p/drug-price/ndc/42858-0002 [2] https://www.pwc.com/us/en/industries/pharma-life-sciences/pharmaceutical-industry-trends.html [5] https://www.labiotech.eu/in-depth/biotech-trends-2025/ [7] https://www.fda.gov/drugs/development-approval-process-drugs/national-drug-code-database-background-information [8] https://www.ajmc.com/view/the-future-of-pharmacy-trends-threats-transformations

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.